COVID-19 Treatment Trial

Skip to Content

COVID-19 Treatment Trial

Learn more

Help people with COVID-19 feel better faster by participating in the ACTIV-6 clinical trial. Learn more about the trial by clicking below to read the flier.

Read the flier.

Help change the future of COVID-19 treatment by participating in a major clinical trial designed to find effective treatments for people with mild to moderate COVID-19.

As our region's MUSC Health affiliate, we are helping recruit volunteers to participate in the ACTIV-6 research study, which is testing several medications approved for other diseases to see if they can help people with COVID-19 feel better and stay out of the hospital.

Eligibility

To be eligible, participants must:

  • Be at least 30 years old
  • Have tested positive for COVID-19 within the past 10 days
  • Have had at least two of the following symptoms:
    • Feeling tired
    • Trouble breathing
    • Fever
    • Cough
    • Upset stomach
    • Vomiting
    • Diarrhea
    • Body aches or chills
    • Headache
    • Sore throat
    • Stuffy nose
    • New loss of sense of taste or smell

If you are selected to participate, you will:

  • Take either a study medication or placebo, as prescribed. A placebo is a medication that has no active ingredients and will have no effect.
  • Answer short surveys daily for 14-28 days. Surveys are taken online on a secure, private website. There are no in-person study visits.
  • Complete a follow-up survey after approximately 90 days.
  • Be part of a group of people across the U.S. who are helping find better treatments for COVID-19.

Find out more

If you are interested in participating in the ACTIV-6 clinical trial or would like to learn more, please call 833-385-1880 or contact Elizabeth Szwast at the Medical University of South Carolina at 843-792-4675 or hinsone@musc.edu.

In the News

Covid 19 Vaccine and Pain Relievers

Flu and Covid Shot Together

COVID-19 Pregnant Women Vaccine

Covid 19 Hits Home

Dont post your vaccination card

COVID-19 Breakthrough Cases

Recent News